AIMS: Research has focused on treatment of overactive bladder (OAB) symptoms in women with the goal of cure. The objective of this study was to assess women's perceptions of their OAB symptoms, treatment experience, and outcomes by conducting patient focus groups. METHODS: Women seen in our academic center female urology referral clinics were identified by ICD-9 codes for OAB symptoms and recruited to participate in one of five focus groups, totaling 33 patients. Non-clinician moderators conducted the focus group sessions incorporating topics related to patients' perceptions of OAB symptoms, treatments, and outcomes. Data analysis was performed using grounded theory methodology. RESULTS: Qualitative analysis yielded several preliminary themes: impact of OAB on quality of life, strategies to control wetness, medications and side effects, and triggers. The majority of focus group participants reported only a partial response to medication and other physician-recommended treatments for OAB. Therefore, they developed self-reliant personalized strategies to improve their quality of life. These strategies included fluid restriction, preventive toileting, and, most importantly, the use of incontinence pads. CONCLUSIONS: The majority of the women who participated in the focus groups reported only a partial response to medical and other treatments for OAB. As a result, they developed personalized self-management strategies to improve their quality of life. Although most studies addressing the treatment of OAB aim at curing the condition, such a strategy may be unrealistic. Applying a chronic care model that uses a patient-centered symptom-management approach to OAB may optimize patient outcomes and improve quality of life.
AIMS: Research has focused on treatment of overactive bladder (OAB) symptoms in women with the goal of cure. The objective of this study was to assess women's perceptions of their OAB symptoms, treatment experience, and outcomes by conducting patient focus groups. METHODS:Women seen in our academic center female urology referral clinics were identified by ICD-9 codes for OAB symptoms and recruited to participate in one of five focus groups, totaling 33 patients. Non-clinician moderators conducted the focus group sessions incorporating topics related to patients' perceptions of OAB symptoms, treatments, and outcomes. Data analysis was performed using grounded theory methodology. RESULTS: Qualitative analysis yielded several preliminary themes: impact of OAB on quality of life, strategies to control wetness, medications and side effects, and triggers. The majority of focus group participants reported only a partial response to medication and other physician-recommended treatments for OAB. Therefore, they developed self-reliant personalized strategies to improve their quality of life. These strategies included fluid restriction, preventive toileting, and, most importantly, the use of incontinence pads. CONCLUSIONS: The majority of the women who participated in the focus groups reported only a partial response to medical and other treatments for OAB. As a result, they developed personalized self-management strategies to improve their quality of life. Although most studies addressing the treatment of OAB aim at curing the condition, such a strategy may be unrealistic. Applying a chronic care model that uses a patient-centered symptom-management approach to OAB may optimize patient outcomes and improve quality of life.
Authors: Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein Journal: Am J Obstet Gynecol Date: 2002-07 Impact factor: 8.661
Authors: W F Stewart; J B Van Rooyen; G W Cundiff; P Abrams; A R Herzog; R Corey; T L Hunt; A J Wein Journal: World J Urol Date: 2002-11-15 Impact factor: 4.226
Authors: Teh-Wei Hu; Todd H Wagner; Judith D Bentkover; Kristi LeBlanc; Amy Piancentini; Walter F Stewart; Ron Corey; Steve Z Zhou; Timothy L Hunt Journal: Urology Date: 2003-06 Impact factor: 2.649
Authors: Gregory Kanter; Katherine A Volpe; Gena C Dunivan; Sara B Cichowski; Peter C Jeppson; Rebecca G Rogers; Yuko M Komesu Journal: Int Urogynecol J Date: 2016-08-31 Impact factor: 2.894
Authors: Jennifer T Anger; Thuy X Le; Helen A Nissim; Lisa Rogo-Gupta; Rezoana Rashid; Ajay Behniwal; Ariana L Smith; Mark S Litwin; Larissa V Rodriguez; Alan J Wein; Sally L Maliski Journal: J Urol Date: 2012-09-19 Impact factor: 7.450
Authors: Nazema Y Siddiqui; Natalie Ammarell; Jennifer M Wu; Juan S Sandoval; Hayden B Bosworth Journal: Female Pelvic Med Reconstr Surg Date: 2016 Sep-Oct Impact factor: 2.091
Authors: Yuko M Komesu; Rebecca G Rogers; Robert E Sapien; Ronald M Schrader; Timothy Simmerman-Sierra; Andrew R Mayer; Loren H Ketai Journal: Int Urogynecol J Date: 2016-10-17 Impact factor: 2.894
Authors: Una J Lee; Victoria C S Scott; Rezoana Rashid; Ajay Behniwal; Alan J Wein; Sally L Maliski; Jennifer T Anger Journal: Urology Date: 2013-02 Impact factor: 2.649
Authors: Jennifer T Anger; Victoria C S Scott; Krista Kiyosaki; Aqsa A Khan; Avivah Weinberg; Sarah E Connor; Carol P Roth; Neil Wenger; Paul Shekelle; Mark S Litwin Journal: Neurourol Urodyn Date: 2013-09-16 Impact factor: 2.696
Authors: Chris Du; Wai Lee; Dena Moskowitz; Alvaro Lucioni; Kathleen C Kobashi; Una J Lee Journal: Int Urogynecol J Date: 2019-12-12 Impact factor: 2.894